Concepedia

Yan Yin

YY

Statistics

Publications

3

Citations

95

H-Index

3

Active since

2022

Affiliations

Sun Yat-sen University(Current)

Sun Yat-sen University Cancer Center

Suzhou Thermal Engineering Research Institute

Vifor Pharma (United States)

Soochow University

Yan Yin is an author at Sun Yat-sen University specializing in bcl-2 inhibition, pharmacology, and bcl2 inhibition.

ORCID

Publications per year

2022–2023

3

Publications

3

Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy

Jing Deng, Aneel Paulus, Douglas D. Fang et al. · Clinical Cancer Research · 2022 · 54 citations

, , +15

First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors

Nehal J. Lakhani, Drew Rasco, Hengbang Wang et al. · Clinical Cancer Research · 2023 · 24 citations

, , +16

Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

Yifan Zhai, Qiuqiong Tang, Douglas D. Fang et al. · Clinical Cancer Research · 2022 · 17 citations · Full text

, , +17

1–3 of 3